Everest Medicines Files Director List with HKEX

Reuters12-11

Everest Medicines Files Director List with HKEX

Everest Medicines Ltd. has released an updated list of its board of directors and their respective roles and committee memberships, filed to the Hong Kong Stock Exchange. The executive directors are Mr. Yifang Wu (Chairman), Mr. Yongqing Luo (Chief Executive Officer), and Mr. Ian Ying Woo (President and Chief Financial Officer). Non-executive directors include Mr. Wei Fu (Honorary Chairman), Mr. William Ki Chul Cho, and Mr. Xin Sun. The independent non-executive directors are Ms. Hoi Yam Chui, Mr. Yifan Li, and Mr. Shidong Jiang. In terms of committee appointments, Mr. Yifan Li serves as Chairperson of the Audit Committee, with Ms. Hoi Yam Chui and Mr. Shidong Jiang as members. Ms. Hoi Yam Chui is the Chairperson of the Remuneration Committee, joined by Mr. Yifang Wu and Mr. Shidong Jiang. Mr. Yifang Wu leads the Nomination Committee as Chairperson, with Ms. Hoi Yam Chui and Mr. Yifan Li as members.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Everest Medicines Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251211-11952314), on December 11, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2590596529?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-11 16:55","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2590596529","market":"us","top_or_hot":-1,"title":"Everest Medicines Files Director List with HKEX","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Everest Medicines Files Director List with HKEX\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Everest Medicines Ltd. has released an updated list of its board of directors and their respective roles and committee memberships, filed to the Hong Kong Stock Exchange. The executive directors are Mr. Yifang Wu (Chairman), Mr. Yongqing Luo (Chief Executive Officer), and Mr. Ian Ying Woo (President and Chief Financial Officer). Non-executive directors include Mr. Wei Fu (Honorary Chairman), Mr. William Ki Chul Cho, and Mr. Xin Sun. The independent non-executive directors are Ms. Hoi Yam Chui, Mr. Yifan Li, and Mr. Shidong Jiang. In terms of committee appointments, Mr. Yifan Li serves as Chairperson of the Audit Committee, with Ms. Hoi Yam Chui and Mr. Shidong Jiang as members. Ms. Hoi Yam Chui is the Chairperson of the Remuneration Committee, joined by Mr. Yifang Wu and Mr. Shidong Jiang. Mr. Yifang Wu leads the Nomination Committee as Chairperson, with Ms. Hoi Yam Chui and Mr. Yifan Li as members.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Everest Medicines Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251211-11952314), on December 11, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Everest Medicines Files Director List with HKEX</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEverest Medicines Files Director List with HKEX\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-12-11 16:55</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Everest Medicines Files Director List with HKEX\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Everest Medicines Ltd. has released an updated list of its board of directors and their respective roles and committee memberships, filed to the Hong Kong Stock Exchange. The executive directors are Mr. Yifang Wu (Chairman), Mr. Yongqing Luo (Chief Executive Officer), and Mr. Ian Ying Woo (President and Chief Financial Officer). Non-executive directors include Mr. Wei Fu (Honorary Chairman), Mr. William Ki Chul Cho, and Mr. Xin Sun. The independent non-executive directors are Ms. Hoi Yam Chui, Mr. Yifan Li, and Mr. Shidong Jiang. In terms of committee appointments, Mr. Yifan Li serves as Chairperson of the Audit Committee, with Ms. Hoi Yam Chui and Mr. Shidong Jiang as members. Ms. Hoi Yam Chui is the Chairperson of the Remuneration Committee, joined by Mr. Yifang Wu and Mr. Shidong Jiang. Mr. Yifang Wu leads the Nomination Committee as Chairperson, with Ms. Hoi Yam Chui and Mr. Yifan Li as members.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Everest Medicines Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251211-11952314), on December 11, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1161","symbol_name":"生物科技","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nNDL6p05PM:1","article_id":"2590596529","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2590596529","pubTimestamp":1765443347,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Everest Medicines Ltd. has released an updated list of its board of directors and their respective roles and committee memberships, filed to the Hong Kong Stock Exchange. The executive directors are Mr. Yifang Wu , Mr. Yongqing Luo , and Mr. Ian Ying Woo . Non-executive directors include Mr. Wei Fu , Mr. William Ki Chul Cho, and Mr. Xin Sun. The independent non-executive directors are Ms. Hoi Yam Chui, Mr. Yifan Li, and Mr. Shidong Jiang. In terms of committee appointments, Mr. Yifan Li serves as Chairperson of the Audit Committee, with Ms. Hoi Yam Chui and Mr. Shidong Jiang as members. Ms. Hoi Yam Chui is the Chairperson of the Remuneration Committee, joined by Mr. Yifang Wu and Mr. Shidong Jiang. Mr. Yifang Wu leads the Nomination Committee as Chairperson, with Ms. Hoi Yam Chui and Mr. Yifan Li as members.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1161":"生物科技","BK1574":"生物医药B类股","BK1583":"高瓴概念","01952":"云顶新耀"},"translate_title":"Everest Medicines向港交所提交董事名单","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01952":0.9},"content_text":"Everest Medicines Files Director List with HKEX\n    \n\n        Everest Medicines Ltd. has released an updated list of its board of directors and their respective roles and committee memberships, filed to the Hong Kong Stock Exchange. The executive directors are Mr. Yifang Wu (Chairman), Mr. Yongqing Luo (Chief Executive Officer), and Mr. Ian Ying Woo (President and Chief Financial Officer). Non-executive directors include Mr. Wei Fu (Honorary Chairman), Mr. William Ki Chul Cho, and Mr. Xin Sun. The independent non-executive directors are Ms. Hoi Yam Chui, Mr. Yifan Li, and Mr. Shidong Jiang. In terms of committee appointments, Mr. Yifan Li serves as Chairperson of the Audit Committee, with Ms. Hoi Yam Chui and Mr. Shidong Jiang as members. Ms. Hoi Yam Chui is the Chairperson of the Remuneration Committee, joined by Mr. Yifang Wu and Mr. Shidong Jiang. Mr. Yifang Wu leads the Nomination Committee as Chairperson, with Ms. Hoi Yam Chui and Mr. Yifan Li as members.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Everest Medicines Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251211-11952314), on December 11, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"executive","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2590596529","isCrawlerRequest":true}